Análisis Argos
CXW
CXWCara
CoreCivic, Inc. · Real Estate
US$ 30.63
precio al 2026-07-28
Valor justo Argos*
US$ 21–24
vs. su valor justo
33% por encima
Score Argos
59/100
LA RESPUESTA
El mercado le pide crezca 11.2% al año — más de lo que ha demostrado (1.6%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
✓Las ganancias crecieron 69% el último año.
✓Reparte dividendo sostenible (5.75%).
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Venta significativa de insiders en el último trimestre.
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
VALOR2/6FUTURO2/6PASADO4/6SALUD2/6DIVIDENDO5/6
El Iris de calidad
VALOR2/6FUTURO2/6PASADO4/6SALUD2/6DIVIDENDO5/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos59de 100Cara
Ingresos▲13%
US$ 2.2 B
Margen operativo▲65%
15.8%
Flujo de caja libre▼75%
US$ 0.1 B
Deuda neta
US$ 1.1 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 3.0B
P/E26x
EV/EBITDA8.7x
FCF yield1.8%
ROIC10.3%
Margen operativo15.8%
Crecim. ingresos+12.7%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

globenewswire.com · 7 jul
CoreCivic Announces 2026 Second Quarter Earnings Release and Conference Call Dates
BRENTWOOD, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it will release its 2026 second quarter financial results after the market closes on Wednesday, August 5, 2026.
globenewswire.com · 6 jul
CoreCivic Sells Two Detention Facilities
BRENTWOOD, Tenn., July 06, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today that on July 2nd, 2026, it completed the sale of its 2,560-bed California City Detention Facility in California City, California (the California City Facility) and its 1,994-bed Otay Mesa Detention Center in San Diego, California (the Otay Mesa Facility) to the United States of America and its assigns, by and through the Department of Homeland Security for an aggregate gross sales price of $1.5 billion, including $732.6 million for the California City Facility and $739.2 million for the Otay Mesa Facility.
wsj.com · 20 jun
Immigration Crackdown Lifts Private-Prison Stocks
So far this year, prison operators Geo Group and CoreCivic are outperforming tech and energy giants alike.
benzinga.com · 16 jun
Top 3 Industrials Stocks That May Keep You Up At Night This Month
As of June 16, 2026, three stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
gurufocus.com · 8 jun
A Look at CoreCivic Inc (CXW) After 6.5% Gain -- GF Value $21.54 vs Price $24.72
On June 08, 2026, CoreCivic Inc (CXW) shares rose 6.5% today, bringing the current price to $24.72. The stock has seen impressive performance in the past weeks,
gurufocus.com · 4 jun
Is CoreCivic Inc (CXW) Overvalued After 6.2% Rally? GF Value Says Overvalued
On June 04, 2026, CoreCivic Inc (CXW) shares rose 6.2% today, bringing the current price to $23.06. The stock has experienced substantial gains over the past mo
marketbeat.com · 9 may
CoreCivic Q1 Earnings Call Highlights
CoreCivic NYSE: CXW reported stronger first-quarter 2026 results and raised its full-year outlook, citing higher demand from federal immigration authorities, the activation of previously idle facilities and the acquisition of Clinical Solutions Pharmacy.
seekingalpha.com · 8 may
CoreCivic, Inc. (CXW) Q1 2026 Earnings Call Transcript
CoreCivic, Inc. (CXW) Q1 2026 Earnings Call Transcript

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.